Rim lesions are demonstrated in early relapsing–remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional setting
Koy Chong Ng Kee Kwong(UK Dementia Research Institute), Adam Waldman(Royal Society of Edinburgh), Michael J. Thrippleton(MRC Centre for Regenerative Medicine), Sarah‐Jane Martin(University of Glasgow), Rozanna Meijboom(MRC Centre for Regenerative Medicine), Siddharthan Chandran(Edinburgh Royal Infirmary), Agniete Kampaite(University of Edinburgh), Daisy Mollison(University of Edinburgh), Elizabeth N. York(University of Edinburgh), David Hunt(Mott MacDonald (United Kingdom))
Cited by 20
Related Papers
Neuroimaging standards for research into small vessel disease—advances since 2013
|The Lancet Neurology|2023|962
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649